Floatz logo

Tetanus-Cmv Fusion Peptide Vaccine

Nodal Marginal Zone B-cell Lymphoma

City of Hope Medical CentervaccinePhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

38 Active assets in the Nodal Marginal Zone B-cell Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
SWOG Cancer Research Network
Phase 2BB
ETOPOSIDE
University of California, Davis
Phase 2BB
Fludarabine
UNC Lineberger Comprehensive Cancer Center
Phase 2BB
Cediranib
National Cancer Institute (NCI)
Phase 2BB
DEXAMETHASONE
Izidore Lossos, MD
Phase 2BB

View all 50 →

Same molecule, other indications

Tetanus-Cmv Fusion Peptide Vaccine is also rated in:

acute myeloid leukemiaDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemia with 11q23 abnormalitiesDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →